Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BAL PHARMA Fact Sheet  (BPHR)



Opportunity Alert: Stocks from India's Emerging Businesses


Here is the latest financial fact sheet of BAL PHARMA. For more details, see the BAL PHARMA quarterly results and BAL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

BAL PHARMA Price History

Price Rs 89.1
Mkt Cap Rs m 1,398
Vol '000 11.5
P/E X 43.8
P/CF X 9.5
EPS (TTM) Rs 2.0
1 Day % 2.3
No. of shares m 15.69
1 Week % 3.2
1 Month % 9.7
1 Year % -10.3
52 week H/L Rs 105.4/63.4
As on Jun 1, 2023 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BAL PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
BAL PHARMA EQUITY SHARE DATA
High Rs1281097973149 
Low Rs7563242953 
Sales per share (Unadj.) Rs146.2158.8120.7169.0189.8 
Earnings per share (Unadj.) Rs0.31.5-9.13.23.8 
Diluted earnings per shareRs0.21.4-8.23.03.6 
Cash flow per share (Unadj.) Rs5.05.9-3.79.69.9 
Dividends per share (Unadj.) Rs1.001.0001.001.00 
Adj. dividends per shareRs0.900.900.000.940.94 
Avg Dividend yield %1.01.202.01.0 
Book value per share (Unadj.) Rs45.947.037.035.538.9 
Adj. book value per shareRs41.442.533.433.636.8 
Shares outstanding (eoy) m14.1714.1714.1714.8214.82 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x0.70.50.40.30.5 
Avg P/E ratio x382.556.5-5.616.026.2 
P/CF ratio (eoy) x20.214.6-13.95.310.1 
Price / Book Value ratio x2.21.81.41.42.6 
Dividend payout %376.965.8031.526.0 
Avg Mkt Cap Rs m1,4401,2177277531,494 
No. of employees `000NANANANANA 
Total wages/salary Rs m522503504419473 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
BAL PHARMA INCOME DATA
Net Sales Rs m2,0712,2501,7112,5052,812 
Other income Rs m1710191152 
Total revenues Rs m2,0882,2601,7292,5172,864 
Gross profit Rs m17317750246240 
Depreciation Rs m6862779590 
Interest Rs m94127127122109 
Profit before tax Rs m29-2-1354192 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m25-24-6-635 
Profit after tax Rs m422-1294757 
Gross profit margin %8.47.92.99.88.5 
Effective tax rate %86.91,166.04.7-14.937.9 
Net profit margin %0.21.0-7.51.92.0 
BAL PHARMA BALANCE SHEET DATA
Current assets Rs m1,8481,8301,5741,6411,846 
Current liabilities Rs m1,5441,6321,5951,5251,656 
Net working cap to sales %14.78.8-1.24.66.7 
Current ratio x1.21.11.01.11.1 
Inventory Days Days7715119 
Debtors Days Days1,1291,0491,058979978 
Net fixed assets Rs m754783810759760 
Share capital Rs m142142142148148 
"Free" reserves Rs m508525383378429 
Net worth Rs m650666524526577 
Long term debt Rs m347288231239270 
Total assets Rs m2,6022,6132,3842,4012,605 
Interest coverage x1.31.0-0.11.31.8 
Debt to equity ratio x0.50.40.40.50.5 
Sales to assets ratio x0.80.90.71.01.1 
Return on assets %3.85.7-0.17.06.4 
Return on equity %0.63.2-24.69.09.9 
Return on capital %12.313.1-1.121.223.7 
Exports to sales %47.756.260.560.065.3 
Imports to sales %19.916.115.622.727.7 
Exports (fob) Rs m9871,2661,0351,5041,836 
Imports (cif) Rs m412362266568779 
Fx inflow Rs m9871,2661,0351,5041,836 
Fx outflow Rs m432390292586796 
Net fx Rs m5568757429181,040 
BAL PHARMA CASH FLOW
From Operations Rs m 6 78 232 223 277 
From Investments Rs m -36 -80 -47 -55 -95 
From Financial Activity Rs m 35 0 -200 -166 -181 
Net Cashflow Rs m 5 -3 -16 2 1 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 51.6%
Institution 0.2%
Non-Institution 48.2%
Total 100.0%
Free Float 48.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2023
 

Company Information

Regd Off #21&22 Bommasandra Industrial Area, Anekal Taluk, Bengaluru - 560099
E-mail investor@balpharma.com Web www.balpharma.com
Tel 080 41379500 Fax 080 41570820 / 22354057
Sector PHARMACEUTICALS Group Private sector
Tr Agent TSR Consultants Pvt Ltd.-(Formerly TSR Darashaw Consultants Pvt Ltd.), C-101 1st Floor, 247 Park Lal Bahadur Shastri Marg, Vikhroli West
CHM: Shailesh Siroya COMP SEC: Preeti Singh YEAR OF INC: 1987 BSE CODE: 524824 FV (Rs): 10 DIV YIELD (%): 1.1

More Pharmaceuticals Company Fact Sheets:   AUROBINDO PHARMA    CIPLA    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    LUPIN    

Compare BAL PHARMA With:   AUROBINDO PHARMA    CIPLA    ZYDUS LIFESCIENCES    PIRAMAL ENTERPRISES    LUPIN    



 

Today's Market

Sensex Today Ends 194 Points Lower, Nifty Below 18,500 | Torrent Pharma Slips 7% | Why Coal India Share Price is Falling Sensex Today Ends 194 Points Lower, Nifty Below 18,500 | Torrent Pharma Slips 7% | Why Coal India Share Price is Falling(Closing)

After opening the day flat, Indian share markets remained subdued throughout the session and ended lower.